Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Antibody immunosuppressive therapy in solid organ transplant: Part II.

Klipa D, Mahmud N, Ahsan N.

MAbs. 2010 Nov-Dec;2(6):607-12. Epub 2010 Nov 1. Review.

2.

Antibody induction therapy for lung transplant recipients.

Penninga L, Møller CH, Penninga EI, Iversen M, Gluud C, Steinbrüchel DA.

Cochrane Database Syst Rev. 2013 Nov 27;(11):CD008927. doi: 10.1002/14651858.CD008927.pub2. Review.

PMID:
24282128
3.

[Monoclonal antibodies in organ transplantation].

Vanhove B.

Med Sci (Paris). 2009 Dec;25(12):1121-5. doi: 10.1051/medsci/200925121121. Review. French.

4.

Current status of immunosuppressive agents for solid organ transplantation in children.

Coelho T, Tredger M, Dhawan A.

Pediatr Transplant. 2012 Mar;16(2):106-22. doi: 10.1111/j.1399-3046.2012.01644.x. Review.

PMID:
22360399
5.
6.

Immunosuppressive T-cell antibody induction for heart transplant recipients.

Penninga L, Møller CH, Gustafsson F, Gluud C, Steinbrüchel DA.

Cochrane Database Syst Rev. 2013 Dec 2;(12):CD008842. doi: 10.1002/14651858.CD008842.pub2. Review.

PMID:
24297433
7.

The use of basiliximab in solid organ transplantation.

Henry ML, Rajab A.

Expert Opin Pharmacother. 2002 Nov;3(11):1657-63. Review.

PMID:
12437498
8.

Induction therapy: why, when, and which agent?

Krischock L, Marks SD.

Pediatr Transplant. 2010 May;14(3):298-313. doi: 10.1111/j.1399-3046.2009.01290.x. Epub 2010 Mar 23. Review.

PMID:
20345609
9.
10.

Daclizumab: a review of its use in the management of organ transplantation.

Carswell CI, Plosker GL, Wagstaff AJ.

BioDrugs. 2001;15(11):745-73. Review.

PMID:
11707149
11.

Basiliximab: a review of its use as induction therapy in renal transplantation.

Chapman TM, Keating GM.

Drugs. 2003;63(24):2803-35. Review.

PMID:
14664658
12.

Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial.

Waid TH, Lucas BA, Thompson JS, McKeown JW, Brown S, Kryscio R, Skeeters LJ.

Transplantation. 1997 Jul 27;64(2):274-81.

PMID:
9256187
13.

Innate immunity in solid organ transplantation: an update and therapeutic opportunities.

Béland S, Désy O, Vallin P, Basoni C, De Serres SA.

Expert Rev Clin Immunol. 2015 Mar;11(3):377-89. doi: 10.1586/1744666X.2015.1008453. Epub 2015 Feb 3. Review.

PMID:
25644774
14.

Muromonab CD3. A review of its pharmacology and therapeutic potential.

Todd PA, Brogden RN.

Drugs. 1989 Jun;37(6):871-99. Review. Erratum in: Drugs 1989 Oct;38(4):followi.

PMID:
2503348
15.

Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.

Webster A, Pankhurst T, Rinaldi F, Chapman JR, Craig JC.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004756. Review.

PMID:
16625610
16.

Immunomodulation of transplant rejection using monoclonal antibodies and soluble receptors.

Alegre ML, Lenschow DJ, Bluestone JA.

Dig Dis Sci. 1995 Jan;40(1):58-64. Review.

PMID:
7821120
17.

New immunosuppressive therapies in renal transplantation: monoclonal antibodies.

Buhaescu I, Segall L, Goldsmith D, Covic A.

J Nephrol. 2005 Sep-Oct;18(5):529-36. Review.

PMID:
16299678
18.

The clinical application of monoclonal antibody therapies in renal transplantation.

Dhanireddy KK, Xu H, Mannon RB, Hale DA, Kirk AD.

Expert Opin Emerg Drugs. 2004 May;9(1):23-37. Review.

PMID:
15155134
19.

Efficacy of alemtuzumab in organ transplantation: current clinical status.

Ciancio G, Burke GW, Warque ME, Miller J.

BioDrugs. 2006;20(2):85-92. Review. Erratum in: BioDrugs. 2007;21(2):77.

PMID:
16626166
20.

New insights into therapy with monoclonal antibodies in allograft transplantation.

Schena FP.

Nephrol Dial Transplant. 1997;12 Suppl 1:55-8. Review. No abstract available.

PMID:
9075230

Supplemental Content

Support Center